Kytopen

Kytopen is a biotechnology company focused on developing and commercializing platforms for accelerating the discovery, development, and manufacturing of gene-modified cell therapies. Their proprietary Flowfect® technology utilizes a combination of microfluidics and automation to enable a non-viral, highly efficient, and scalable gene delivery solution. This unique approach aims to address the challenges associated with current gene delivery methods, making the process easier, faster, and more cost-effective. Kytopen's mission is to revolutionize the field of gene delivery and cell therapy discovery through manufacturing, thereby increasing patient access to life-saving therapies.

Kytopen offers two primary platforms: Flowfect Discover™ for automated high-throughput screening and optimization, and Flowfect Tx™ for large-scale manufacturing. The company has established strategic partnerships with industry-leading contract development and manufacturing organizations (CDMOs) and translational academic medical centers. Through these partnerships, Kytopen aims to bridge the gap between discovery and manufacturing, helping therapeutic developers overcome manufacturing challenges at the discovery stage and ultimately accelerating the development of new and innovative cell therapies.

Kytopen offers flexible work options with its employees able to work remotely from a Denver, Colorado office in addition to its main Cambridge, Massachusetts office.

Kytopen's mission is to accelerate the future of medicine by expanding patient access to next-generation cell therapies through scalable genome engineering platforms. They achieve this by solving cell therapy manufacturing problems at the discovery stage, enabling researchers and developers to accelerate drug discovery, expedite optimization, and remove barriers to biomanufacturing scaling. Their non-viral gene delivery platform, Flowfect®, allows for efficient cell engineering from discovery through manufacturing, ultimately maximizing yields of engineered therapeutics.

Kytopen promotes a collaborative and innovative culture focused on achieving breakthroughs in gene delivery and cell therapy. They value the input of their diverse team, foster a spirit of learning and exploration, and are driven by a shared mission to make life-saving therapies more accessible. This is evident in their initiatives like the Technology Access Program, which encourages close partnerships and knowledge sharing, and their celebration of International Women in Engineering Day, highlighting the importance of diversity and inclusion within their workforce.